parthenolide and Local Neoplasm Recurrence

parthenolide has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Araújo, TG; Brandão, DC; Campos, IM; Ferreira, EA; Filho, AADS; Guimarães, GS; Lima, PMAP; Ribeiro, MA; Vecchi, L	1
Aviles-Vazquez, S; Ayala-Sanchez, M; Chávez-González, A; Crooks, PA; Flores-Lopez, G; Guzman, ML; Mayani, H; Moreno-Lorenzana, D; Torres-Martinez, H	1

Reviews

1 review(s) available for parthenolide and Local Neoplasm Recurrence

Article	Year
Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors. Current medicinal chemistry, 2020, Volume: 27, Issue:39 Topics: Apoptosis; Cell Line, Tumor; Humans; Neoplasm Recurrence, Local; Sesquiterpenes; Triple Negative Breast Neoplasms	2020

Other Studies

1 other study(ies) available for parthenolide and Local Neoplasm Recurrence

Article	Year
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10 Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction	2018

Article

Year

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.

Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10

Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction

2018